Safusidenib (AB-218, DS-1001)
G307
Nuvation Bio · Phase 3 · Not yet recruiting · Enrollment 140
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
Disease Pipeline Tools IDH-mutant glioma
IDH-mutant glioma
Programs, trials, and reported response and survival for IDH-mutant glioma.
Safusidenib (AB-218, DS-1001)
Nuvation Bio · Phase 3 · Not yet recruiting · Enrollment 140
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.